Video Experimental Relacionado

Updated: Jul 15, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

Eficacia de la vacuna conjugada meningocócica serogrupo C 4 años después de la introducción

Caroline L Trotter¹, Nick J Andrews, Edward B Kaczmarski

¹Statistics, Economics, and Modelling Department, Health Protection Agency Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, UK.

Lancet (London, England)

|July 28, 2004

Resumen

La vacuna meningocócica serogrupo C conjugado (MCC) muestra una alta eficacia a corto plazo, pero disminuye rápidamente en los bebés. Se necesitan programas alternativos de inmunización infantil para mantener la protección a largo plazo contra la enfermedad meningocócica serogrupo C.

Área de la Ciencia:

Inmunología Inmunología.
Vacunología Vacunología.
Salud Pública La salud pública.

Sus antecedentes:

Las vacunas de serogrupo C meningocócico conjugado (MCC) redujeron con éxito la incidencia de la enfermedad en Inglaterra.
La alta efectividad a corto plazo y la inmunidad de grupo contribuyeron al éxito del programa.
La eficacia de la vacuna a largo plazo en Inglaterra sigue siendo en gran medida desconocida.

Objetivo del estudio:

Evaluar la eficacia a largo plazo de la vacuna MCC en Inglaterra.
Para evaluar la efectividad de la vacuna en diferentes cohortes de vacunación.
Para informar futuras estrategias de inmunización.

Principales métodos:

Análisis de los datos de vigilancia de los 4 años posteriores a la introducción del programa de vacunación contra el MCC.
Evaluación de la eficacia de la vacuna en niños vacunados a través de campañas de recuperación.
Evaluación de la eficacia de la vacuna en los bebés que reciben la inmunización de rutina.

Principales resultados:

Se observó una alta eficacia sostenida de la vacuna en los niños vacunados durante la campaña de recuperación.
Significativa disminución de la efectividad de la vacuna MCC a niveles bajos dentro de 1 año para los bebés en el programa de inmunización de rutina.
Se observó un bajo número de individuos en las cohortes de bebés afectados.

Conclusiones:

Si bien la vacuna MCC es efectiva a corto plazo, su durabilidad en la inmunización infantil de rutina es limitada.
Se deben explorar programas alternativos de inmunización infantil para garantizar una protección sostenida.
El monitoreo continuo es crucial para el control a largo plazo de la enfermedad.

Más Videos Relacionados

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8⁺ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Videos de Conceptos Relacionados

Vaccinations

Vaccinations

Immunological Memory

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Viral Meningitis

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

Cryptococcal Meningitis

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...